Literature DB >> 24846033

Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.

Boris Pasche1, Stefan C Grant2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24846033     DOI： 10.1001/jama.2014.3742

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.

Authors:  Xiaoli Li; Jian Liu; Li Qian; Honggang Ke; Chan Yao; Wei Tian; Yifei Liu; Jianguo Zhang
Journal:  Mol Cell Biochem       Date:  2018-01-11       Impact factor: 3.396

2.  PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.

Authors:  Liping Yang; Panpan Xu; Mengyue Li; Menglu Wang; Mengye Peng; Ying Zhang; Tingting Wu; Wenjie Chu; Kezheng Wang; Hongxue Meng; Lingbo Zhang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

4.  Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.

Authors:  Mukesh Verma; Tram Kim Lam; Elizabeth Hebert; Rao L Divi
Journal:  BMC Clin Pathol       Date:  2015-04-15

5.  Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.

Authors:  Tao Ren; Jinlu Shan; Mengxia Li; Yi Qing; Chengyuan Qian; Guangjie Wang; Qing Li; Guoshou Lu; Chongyi Li; Yu Peng; Hao Luo; Shiheng Zhang; Yuxing Yang; Yi Cheng; Dong Wang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-06-08       Impact factor: 4.162

6.  Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.

Authors:  Ville Kytola; Umit Topaloglu; Lance D Miller; Rhonda L Bitting; Michael M Goodman; Ralph B D Agostino; Rodwige J Desnoyers; Carol Albright; George Yacoub; Shadi A Qasem; Barry DeYoung; Vesteinn Thorsson; Ilya Shmulevich; Meng Yang; Anastasia Shcherban; Matthew Pagni; Liang Liu; Matti Nykter; Kexin Chen; Gregory A Hawkins; Stefan C Grant; W Jeffrey Petty; Angela Tatiana Alistar; Edward A Levine; Edgar D Staren; Carl D Langefeld; Vincent Miller; Gaurav Singal; Robin M Petro; Mac Robinson; William Blackstock; Bayard L Powell; Lynne I Wagner; Kristie L Foley; Edward Abraham; Boris Pasche; Wei Zhang
Journal:  Theranostics       Date:  2017-07-12       Impact factor: 11.556

7.  Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma.

Authors:  Mengnan Zhao; Cheng Zhan; Ming Li; Xiaodong Yang; Xinyu Yang; Yong Zhang; Miao Lin; Yifeng Xia; Mingxiang Feng; Qun Wang
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 8.  Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.

Authors:  Zilan Zhu; Ziyi Zheng; Jian Liu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

Review 9.  Gene aberrations for precision medicine against lung adenocarcinoma.

Authors:  Motonobu Saito; Kouya Shiraishi; Hideo Kunitoh; Seiichi Takenoshita; Jun Yokota; Takashi Kohno
Journal:  Cancer Sci       Date:  2016-05-25       Impact factor: 6.716

10.  The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine.

Authors:  Louis D Fiore; Mary T Brophy; Sara Turek; Valmeek Kudesia; Nithya Ramnath; Colleen Shannon; Ryan Ferguson; Saiju Pyarajan; Melissa A Fiore; John Hornberger; Philip Lavori
Journal:  Biomark Cancer       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.